Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A new design for randomized clinical trials.

The New England Journal of Medicine

|May 31, 1979

Summary

This summary is machine-generated.

This study introduces a new randomized clinical trial design for comparing experimental treatments against standard care. Patients know their treatment allocation before consent, enhancing ethical considerations in clinical research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The training of biostatistical scientists.

Statistics in medicine·2003

Same author

Referent sampling, family history and relative risk: the role of length-biased sampling.

Biostatistics (Oxford, England)·2003

Same author

Modelling the early detection of breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2003

Same author

Testing the independence of two diagnostic tests.

Biometrics·2002

Same author

Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Same author

Comparing the survival of two groups with an intermediate clinical event.

Lifetime data analysis·2001

Same journal

Ebola at 50 - Lessons for Outbreak Response and Preparedness.

The New England journal of medicine·2026

Same journal

Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.

The New England journal of medicine·2026

Same journal

Ianalumab plus Eltrombopag in Immune Thrombocytopenia.

The New England journal of medicine·2026

Same journal

Hypertension Control in Low-Income Patients. Reply.

The New England journal of medicine·2026

Same journal

Hypertension Control in Low-Income Patients.

The New England journal of medicine·2026

Same journal

Hypertension Control in Low-Income Patients.

The New England journal of medicine·2026

See all related articles

Area of Science:

Clinical Trials
Medical Research Methodology
Biostatistics

Background:

Standard clinical trial designs may not fully inform patients about experimental treatment allocation before consent.
Comparing novel therapies with established treatments requires robust and ethical methodologies.

Purpose of the Study:

To propose a novel randomized clinical trial design for comparing experimental treatments with a best standard or control.
To enhance patient understanding and consent processes in clinical trials.

Main Methods:

Patients are randomized into two groups: one receives standard treatment, the other is offered experimental therapy.
Patients declining experimental therapy receive the best standard treatment.
Analysis compares all patients in the second group (regardless of final treatment) with the first group.

Related Experiment Videos

Main Results:

The proposed method constitutes a valid randomized clinical trial.
Statistical efficiency can be maintained by increasing sample size to compensate for potential treatment deviations within groups.
Patients gain knowledge of potential experimental treatment use prior to providing informed consent.

Conclusions:

This novel trial design improves patient awareness and informed consent.
The method offers a flexible approach for comparing experimental and standard treatments in clinical research.
Adaptability through increased sample size ensures statistical validity.